BROADFIN CAPITAL, LLC Information

237 PARK AVENUE, 9TH FLOOR, NEW YORK, New York, 10017, (212) 808-2463

Report Date: 09/30/2014

Position Statistics

Total Positions 78
New Positions 10
Increased Positions 26
Decreased Positions 28
Positions with Activity 54
Sold Out Positions 8
Total Mkt Value (in $ millions) 1,151

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 0.58%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial 1.51%
Healthcare 87.17%
Services 1.29%
Technology
Transportation
Utilities

78 Positions as of 09/30/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
NOVADAQ TECHNOLOGIES INC COM 3,177 -16,398 (83.77) 195,017
RECRO PHARMA INC COM 3,177 1,355 74.38 1,172,195
ONCOTHYREON INC COM 2,700 2,700 New 1,500,000
CELSUS THERAPEUTICS PLC SPONSORED ADR NE 2,307 New 470,877
ANTHERA PHARMACEUTICALS INC COM NEW 2,057 846 69.85 1,301,622
BIODEL INC COM NEW 1,849 New 1,330,034
RXI PHARMACEUTICALS CORP NEW COM NEW 1,802 New 1,126,482
TONIX PHARMACEUTICALS HLDG COR COM NEW 1,650 -1,142 (40.9) 276,394
IGNYTA INC COM 1,526 New 225,000
DIGIRAD CORP COM 1,283 New 332,480
AGENUS INC COM NEW -4,712 Sold Out 0
AUXILIUM PHARMACEUTICALS INC COM -10,410 Sold Out 0
BIOSCRIP INC COM -7,031 Sold Out 0
CAREFUSION CORP COM -7,394 Sold Out 0
HAEMONETICS CORP COM -136 Sold Out 0
LIPOCINE INC NEW COM -1,356 Sold Out 0
POZEN INC COM -5,390 Sold Out 0
SAGENT PHARMACEUTICALS INC COM -8,625 Sold Out 0


Latest News Headlines

View All
Create your free portfolio